TVM Capital
Europe, Bayern, Germany, Munich
Description
TVM Capital is a global venture and growth capital firm that aims to finance select biopharmaceutical and medical device companies.
Investor Profile
TVM Capital has made 101 investments, with 0 in the past 12 months and 19% as lead.
Stage Focus
- Series B (27%)
- Series Unknown (24%)
- Series C (18%)
- Series A (17%)
- Series D (10%)
- Series E (3%)
- Seed (1%)
- Series F (1%)
Country Focus
- United States (55%)
- Germany (21%)
- United Kingdom (10%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- The Netherlands (3%)
- Denmark (2%)
- France (2%)
- Switzerland (2%)
- Italy (2%)
- Ireland (1%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Sweden (1%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Software
- Manufacturing
- Medical
- Therapeutics
- Wireless
- Health Diagnostics
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
